What is the current status of targeted therapies to treat pancreatic cancer?

Topic Tags:  
Topic Tags:  
Diseases:  
Diseases:  
Emailz
1
Expert Answers

StevenLibuttiMD (Physician (Verified) ) - 08 / 05 / 2012

I think there is a lot of excitement surrounding pancreatic cancer research right now in light of the identification of important pathways involved in the development and progression of both adenocarcinoma and neuroendocrine tumors. Therapies can be targeted against a specific pathway, or targeted directly to the tumor cells themselves to avoid systemic toxicity.

Mutations in genes such as BRCA2 and KRAS, which can lead to pancreatic adenocarcinoma have been identified and open the possibility of understanding these pathways better and developing therapies to block them. Similarly, mutations in genes like MEN1, and DAXX have been shown to be important for the development and progression of pancreatic neuroendocrine tumors.

Currently, new targeted therapies such as EGF receptor inhibitors like erlotinib for pancreatic adenocarcinoma and mTOR inhibitors like everolimus for pancreatic neuroendocrine tumors are showing promise. Clearly, we need more and better agents, but the greater understanding we are developing of how these tumors form and progress will hopefully lead to more effective treatment strategies.
Join Now to ask a follow-up question or share your experience!
We'll help guide and support you through treatments.
Similar Questions
What is the current state of using targeted therapies to treat brain cancer?
Would you share about the current status of targeted therapies for bladder cancer?
What is the current status of targeted therapies for myelodysplastic syndrome (MDS)?
What is the current status of targeted therapies for AML (acute myeloid leukemia)?
What is the current status of targeted therapies in head and neck cancers?
Note: All content on this site is informational and not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with questions regarding your health.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.
Flag Content
Please explain why you are flagging this content. Thank you.
Thank you for flagging this content. We will look into it right away.
Give a 'Thank you' to
Close
Talk About Health
Add Answer

Close
1) Question:
2) Background Info (optional): What context or background information is relevant to this request?
Notes:
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information or english might not be their first language. Please use standard english and spell out all words. For example, use 'you' instead of 'u'.
Newsletters
Close
Subscribe to our free updates for the latest news, best answers and featured experts!
Your Email:
Q&A Workshop Announcements
(Featured experts, answers, tips, & latest news.)
Q&A Workshop Summaries
(Answer summaries from our expert Q&A workshops.)
Best of TalkAboutHealth (weekly)
(The week's best answers, news & support.)
TalkAboutHealth Benefits
(Custom health, wellness & medical promotions from our partners including clinical trials, market research opportunities, & new programs.)

Partners become a partner

© Copyright 2013 - Talk About Health - Privacy Policy | Terms of Service